Diary - News
All news Biom’up announces first sales of HEMOBLASTTM Bellows in the United States
Saint-Priest, France, July 3, 2018 – Biom’up (the “Company”), specialist of surgical hemostasis, announces today its first commercial results in the North American market, early proof points of the strength of its US sales infrastructure.
A first shipment of its flagship product HEMOBLAST Bellows from the Company’s French production site in Saint-Priest to the Company’s central logistic hub in the US in June confirmed that the supply chain is operational, reliable and fully compliant with US regulations.
By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree